Oswald AJ, Symeonides SN, Wheatley D, Chan S, et al. Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study. Breast Cancer Res Treat 2023 Mar 2. doi: 10.1007/s10549-023-06873.
PMID: 36859649